Challenges in understanding the genomic landscape of Hodgkin lymphoma

Sven Borchmann, MD, University of Cologne, Cologne, Germany, discusses the challenges in understanding the genomic landscape of Hodgkin lymphoma (HL), particularly compared to solid tumors. Dr Borchmann highlights the benefits of using circulating tumor DNA (ctDNA) to study HL genomics. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.